Bavarian Nordic A/S (CPH:BAVA)
Denmark · Delayed Price · Currency is DKK 235.60
-1.90 (-0.80%)
Aug 1, 2025, 4:59 PM CET
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of 18.34 billion as of August 1, 2025. Its market cap has increased by 28.97% in one year.
Market Cap
18.34B
Enterprise Value
17.22B
Revenue
6.23B
Ranking
n/a
PE Ratio
14.18
Stock Price
235.60
Market Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 42.71M to 18.34B, an increase of 42,836.09%. That is a compound annual growth rate of 25.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 18.34B | 23.27% |
| Dec 30, 2024 | 14.88B | 7.57% |
| Dec 29, 2023 | 13.83B | -8.19% |
| Dec 30, 2022 | 15.06B | -20.32% |
| Dec 30, 2021 | 18.90B | 73.28% |
| Dec 30, 2020 | 10.91B | 96.88% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,370.78B |
| Coloplast | 133.61B |
| Genmab | 85.30B |
| Demant | 52.15B |
| ALK-Abelló | 41.80B |
| H. Lundbeck | 32.40B |
| Ambu A/S | 24.51B |
| Zealand Pharma | 23.25B |